Fumihiro Jinno

Phase I first-in-human study of TAK-285, a novel investigational dual HER2/EGFR inhibitor, in cancer patients

Toshihiko Doi, Hiroya Takiuchi, Atsushi Ohtsu et al. · British Journal of Cancer · 2012 · 42 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +15

A validated simultaneous quantification method for vonoprazan (TAK-438F) and its 4 metabolites in human plasma by the liquid chromatography-tandem mass spectrometry

Tomoki Yoneyama, Koichiro Teshima, Fumihiro Jinno et al. · Journal of Chromatography B · 2016 · 40 citations

Life Sciences, Pharmaceutical Analysis, Pharmacology +16

Structural determination of a new mutagenic heterocydic amine, 2-amino-1,7,9-trimethylimidazo[4,5-g]quinoxaline (7,9-DiMeIgQx), present in beef extract

Haruo Nukaya, Souichi Koyota, Fumihiro Jinno et al. · Carcinogenesis · 1994 · 21 citations

Agriculture, Microbiology, Toxicology +8

Bioanalytical method for the simultaneous determination of d- and l-serine in human plasma by LC/MS/MS

Hiroshi Sugimoto, Masaaki Kakehi, Fumihiro Jinno · Analytical Biochemistry · 2015 · 18 citations

Pharmacy, Biochemistry, Pharmaceutical Analysis +16

Bioanalysis of farnesyl pyrophosphate in human plasma by high-performance liquid chromatography coupled to triple quadrupole tandem mass spectrometry and hybrid quadrupole Orbitrap high-resolution mass spectrometry

Hiroshi Sugimoto, Mie Iguchi, Fumihiro Jinno · Analytical and Bioanalytical Chemistry · 2017 · 17 citations

Pharmacy, Biochemistry, Analytical Chemistry +14